Negative	O
regulation	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
expression	O
in	O
monocytes	O
:	O
role	O
of	O
the	O
65-kDa	B-protein
plus	O
50-kDa	B-protein
NF-kappa	I-protein
B	I-protein
dimer	I-protein
.	O

Although	O
monocytic	O
cells	O
can	O
provide	O
a	O
reservoir	O
for	O
viral	O
production	O
in	O
vivo	O
,	O
their	O
regulation	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
transcription	O
can	O
be	O
either	O
latent	O
,	O
restricted	O
,	O
or	O
productive	O
.	O

These	O
differences	O
in	O
gene	O
expression	O
have	O
not	O
been	O
molecularly	O
defined	O
.	O

In	O
THP-1	B-cell_line
cells	I-cell_line
with	O
restricted	O
HIV	O
expression	O
,	O
there	O
is	O
an	O
absence	O
of	O
DNA-protein	B-protein
binding	I-protein
complex	I-protein
formation	O
with	O
the	O
HIV-1	B-DNA
promoter-enhancer	I-DNA
associated	O
with	O
markedly	O
less	O
viral	B-RNA
RNA	I-RNA
production	O
.	O

This	O
absence	O
of	O
binding	O
was	O
localized	O
to	O
the	O
NF-kappa	B-DNA
B	I-DNA
region	I-DNA
of	O
the	O
HIV-1	B-DNA
enhancer	I-DNA
;	O
the	O
65-kDa	B-protein
plus	I-protein
50-kDa	I-protein
NF-kappa	I-protein
B	I-protein
heterodimer	I-protein
was	O
preferentially	O
lost	O
.	O

Adding	O
purified	O
NF-kappa	B-protein
B	I-protein
protein	I-protein
to	O
nuclear	O
extracts	O
from	O
cells	O
with	O
restricted	O
expression	O
overcomes	O
this	O
lack	O
of	O
binding	O
.	O

In	O
addition	O
,	O
treatment	O
of	O
these	O
nuclear	O
extracts	O
with	O
sodium	O
deoxycholate	O
restored	O
their	O
ability	O
to	O
form	O
the	O
heterodimer	B-protein
,	O
suggesting	O
the	O
presence	O
of	O
an	O
inhibitor	O
of	O
NF-kappa	B-protein
B	I-protein
activity	O
.	O

Furthermore	O
,	O
treatment	O
of	O
nuclear	O
extracts	O
from	O
these	O
cells	O
that	O
had	O
restricted	O
expression	O
with	O
lipopolysaccharide	O
increased	O
viral	O
production	O
and	O
NF-kappa	B-protein
B	I-protein
activity	O
.	O

Antiserum	O
specific	O
for	O
NF-kappa	B-protein
B	I-protein
binding	I-protein
proteins	I-protein
,	O
but	O
not	O
c-rel-specific	O
antiserum	O
,	O
disrupted	O
heterodimer	B-protein
complex	I-protein
formation	O
.	O

Thus	O
,	O
both	O
NF-kappa	B-protein
B-binding	I-protein
complexes	I-protein
are	O
needed	O
for	O
optimal	O
viral	O
transcription	O
.	O

Binding	O
of	O
the	O
65-kDa	B-protein
plus	O
50-kDa	B-protein
heterodimer	I-protein
to	O
the	O
HIV-1	B-DNA
enhancer	I-DNA
can	O
be	O
negatively	O
regulated	O
in	O
monocytes	B-cell_type
,	O
providing	O
one	O
mechanism	O
restricting	O
HIV-1	B-DNA
gene	I-DNA
expression	O
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

88	NULL
,	NULL
pp	NULL
.	NULL

9426-9430	NULL
,	NULL
November	NULL
1991	NULL
Microbiology	NULL
Negative	NULL
regulation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
expression	NULL
in	NULL
monocytes	NULL
:	NULL
Role	NULL
of	NULL
the	NULL
65-kDa	NULL
plus	NULL
50-kDa	NULL
NF-B	NULL
dimer	NULL
(	NULL
retroviral	NULL
transcription	NULL
/monocyte	NULL
activation	NULL
)	NULL
Raziuppin*	NULL
,	NULL
Juby	NULL
A.	NULL
MiKovits*	NULL
,	NULL
Ipa	NULL
CaLvERT	NULL
!	NULL

,	NULL
Sankar	NULL
Guosut	NULL
,	NULL
Hstancg-ru	NULL
Kunot	NULL
,	NULL
AND	NULL
Francis	NULL
W.	NULL
RuscetTi	NULL
$	NULL
!	NULL

*Biological	NULL
Carcinogenesis	NULL
and	NULL
Development	NULL
Program	NULL
,	NULL
Program	NULL
Resources	NULL
,	NULL
Inc./DynCorp	NULL
,	NULL
and	NULL
Laboratory	NULL
of	NULL
Biochemical	NULL
Physiology	NULL
and	NULL
$	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Immunoregulation	NULL
,	NULL
Biological	NULL
Response	NULL
Modifiers	NULL
Program	NULL
,	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
Frederick	NULL
Cancer	NULL
Research	NULL
and	NULL
Development	NULL
Center	NULL
,	NULL
Frederick	NULL
,	NULL
MD	NULL
21702-1201	NULL
;	NULL
and	NULL
*Whitehead	NULL
Institute	NULL
for	NULL
Biomedical	NULL
Research	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
02142	NULL
Communicated	NULL
by	NULL
C.	NULL
C.	NULL
Tan	NULL
,	NULL
July	NULL
22	NULL
,	NULL
1991	NULL
ABSTRACT	NULL
Although	NULL
monocytic	NULL
cells	NULL
can	NULL
provide	NULL
a	NULL
reservoir	NULL
for	NULL
viral	NULL
production	NULL
in	NULL
vivo	NULL
,	NULL
their	NULL
regulation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
transcription	NULL
can	NULL
be	NULL
either	NULL
latent	NULL
,	NULL
restricted	NULL
,	NULL
or	NULL
productive	NULL
.	NULL

These	NULL
differences	NULL
in	NULL
gene	NULL
expression	NULL
have	NULL
not	NULL
been	NULL
molecularly	NULL
defined	NULL
.	NULL

In	NULL
THP-1	NULL
cells	NULL
with	NULL
restricted	NULL
HIV	NULL
expression	NULL
,	NULL
there	NULL
is	NULL
an	NULL
absence	NULL
of	NULL
DNA-protein	NULL
binding	NULL
complex	NULL
formation	NULL
with	NULL
the	NULL
HIV-1	NULL
pro-moter-enhancer	NULL
associated	NULL
with	NULL
markedly	NULL
less	NULL
viral	NULL
RNA	NULL
production	NULL
.	NULL

This	NULL
absence	NULL
of	NULL
binding	NULL
was	NULL
localized	NULL
to	NULL
the	NULL
NF-xB	NULL
region	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
;	NULL
the	NULL
65-kDa	NULL
plus	NULL
50-kDa	NULL
NF-sB	NULL
heterodimer	NULL
was	NULL
preferentially	NULL
lost	NULL
.	NULL

Adding	NULL
purified	NULL
NF-xB	NULL
protein	NULL
to	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
with	NULL
restricted	NULL
expression	NULL
overcomes	NULL
this	NULL
lack	NULL
of	NULL
binding	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
treatment	NULL
of	NULL
these	NULL
nuclear	NULL
extracts	NULL
with	NULL
sodium	NULL
deoxycholate	NULL
restored	NULL
their	NULL
ability	NULL
to	NULL
form	NULL
the	NULL
heterodimer	NULL
,	NULL
suggesting	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
inhibitor	NULL
of	NULL
activity	NULL
.	NULL

Furthermore	NULL
,	NULL
treatment	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
these	NULL
cells	NULL
that	NULL
had	NULL
restricted	NULL
expression	NULL
with	NULL
lipopolysaccharide	NULL
increased	NULL
viral	NULL
production	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
.	NULL

Antiserum	NULL
specific	NULL
for	NULL
NF-B	NULL
binding	NULL
proteins	NULL
,	NULL
but	NULL
not	NULL
c-rel-specific	NULL
antiserum	NULL
,	NULL
disrupted	NULL
heterodimer	NULL
complex	NULL
formation	NULL
.	NULL

Thus	NULL
,	NULL
both	NULL
NF-xB-binding	NULL
complexes	NULL
are	NULL
needed	NULL
for	NULL
optimal	NULL
viral	NULL
transcription	NULL
.	NULL

Binding	NULL
of	NULL
the	NULL
65-kDa	NULL
plus	NULL
50-kDa	NULL
heterodimer	NULL
to	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
can	NULL
be	NULL
negatively	NULL
regulated	NULL
in	NULL
monocytes	NULL
,	NULL
providing	NULL
one	NULL
mechanism	NULL
restricting	NULL
HIV-1	NULL
gene	NULL
expression	NULL
.	NULL

Infection	NULL
by	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
is	NULL
clinically	NULL
characterized	NULL
by	NULL
a	NULL
long	NULL
latent	NULL
period	NULL
preceding	NULL
the	NULL
development	NULL
of	NULL
overt	NULL
symptoms	NULL
of	NULL
AIDS	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Several	NULL
studies	NULL
have	NULL
indicated	NULL
that	NULL
a	NULL
persistent	NULL
state	NULL
of	NULL
either	NULL
latent	NULL
or	NULL
chronic	NULL
low-level	NULL
(	NULL
restricted	NULL
)	NULL
infection	NULL
can	NULL
be	NULL
found	NULL
in	NULL
both	NULL
fresh	NULL
and	NULL
cultured	NULL
cells	NULL
(	NULL
2-4	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
elucidating	NULL
the	NULL
mechanisms	NULL
that	NULL
control	NULL
viral	NULL
replication	NULL
may	NULL
have	NULL
important	NULL
clinical	NULL
implications	NULL
in	NULL
understanding	NULL
AIDS	NULL
disease	NULL
progres-sion	NULL
.	NULL

Of	NULL
particular	NULL
interest	NULL
are	NULL
factors	NULL
that	NULL
could	NULL
play	NULL
a	NULL
role	NULL
in	NULL
suppressing	NULL
HIV	NULL
expression	NULL
in	NULL
cells	NULL
containing	NULL
integrated	NULL
proviruses	NULL
.	NULL

Because	NULL
animal	NULL
lentiviruses	NULL
show	NULL
a	NULL
tropism	NULL
for	NULL
the	NULL
mono-cyte	NULL
cell	NULL
lineage	NULL
during	NULL
viral	NULL
persistence	NULL
(	NULL
5	NULL
)	NULL
and	NULL
HIV-1	NULL
infects	NULL
human	NULL
monocytes	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
,	NULL
these	NULL
cells	NULL
probably	NULL
serve	NULL
as	NULL
circulating	NULL
or	NULL
tissue	NULL
reservoirs	NULL
for	NULL
HIV-1	NULL
.	NULL

To	NULL
study	NULL
the	NULL
regulatory	NULL
mechanisms	NULL
controlling	NULL
HIV-1	NULL
gene	NULL
expression	NULL
in	NULL
monocytes	NULL
,	NULL
our	NULL
laboratory	NULL
has	NULL
recently	NULL
established	NULL
chronically	NULL
infected	NULL
cultures	NULL
of	NULL
a	NULL
monocytic	NULL
cell	NULL
line	NULL
,	NULL
THP-1	NULL
,	NULL
with	NULL
various	NULL
levels	NULL
of	NULL
HIV-1	NULL
expression	NULL
(	NULL
2	NULL
)	NULL
.	NULL

These	NULL
cells	NULL
express	NULL
either	NULL
no	NULL
(	NULL
latent	NULL
)	NULL
,	NULL
low	NULL
(	NULL
restricted	NULL
)	NULL
,	NULL
or	NULL
high	NULL
(	NULL
productive	NULL
)	NULL
HIV-1	NULL
levels	NULL
.	NULL

In	NULL
cells	NULL
with	NULL
restricted	NULL
expression	NULL
,	NULL
many	NULL
inductive	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

9426	NULL
signals	NULL
,	NULL
such	NULL
as	NULL
mitogens	NULL
(	NULL
8	NULL
)	NULL
and	NULL
cytokines	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
,	NULL
increase	NULL
viral	NULL
production	NULL
;	NULL
however	NULL
,	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
viral	NULL
expression	NULL
is	NULL
negatively	NULL
regulated	NULL
in	NULL
these	NULL
cells	NULL
are	NULL
poorly	NULL
understood	NULL
.	NULL

One	NULL
transcription	NULL
factor	NULL
responsive	NULL
to	NULL
immune	NULL
activation	NULL
is	NULL
nuclear	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
which	NULL
stimulates	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
monocytes	NULL
treated	NULL
with	NULL
various	NULL
agents	NULL
,	NULL
including	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
,	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
(	NULL
12	NULL
)	NULL
,	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
recognizes	NULL
an	NULL
11-base	NULL
pair	NULL
(	NULL
bp	NULL
)	NULL
DNA	NULL
sequence	NULL
present	NULL
in	NULL
the	NULL
immunoglobulin	NULL
light	NULL
chain	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Similar	NULL
sequences	NULL
are	NULL
found	NULL
in	NULL
the	NULL
genes	NULL
encoding	NULL
class	NULL
I	NULL
major	NULL
histocompat-ibility	NULL
antigens	NULL
(	NULL
16	NULL
)	NULL
,	NULL
interleukin	NULL
2	NULL
receptor	NULL
a	NULL
chain	NULL
(	NULL
17	NULL
)	NULL
,	NULL
and	NULL
several	NULL
cytokines	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Mutations	NULL
in	NULL
the	NULL
xB-binding	NULL
sites	NULL
that	NULL
abolish	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
prevent	NULL
inducibility	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
.	NULL

Two	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
proteins-a	NULL
50-kDa	NULL
protein	NULL
(	NULL
p50	NULL
)	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
and	NULL
a	NULL
65-kDa	NULL
protein	NULL
(	NULL
p65	NULL
)	NULL
(	NULL
22	NULL
)	NULL
-have	NULL
recently	NULL
been	NULL
cloned	NULL
and	NULL
show	NULL
considerable	NULL
homology	NULL
to	NULL
c-rel	NULL
.	NULL

The	NULL
p50	NULL
can	NULL
form	NULL
a	NULL
homodimer	NULL
and	NULL
a	NULL
heterodimer	NULL
with	NULL
p65	NULL
,	NULL
which	NULL
bind	NULL
to	NULL
DNA	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
this	NULL
heterodimer	NULL
can	NULL
be	NULL
negatively	NULL
regulated	NULL
in	NULL
HIV-1-infected	NULL
monocytes	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
infected	NULL
with	NULL
HIV-1	NULL
,	NULL
as	NULL
described	NULL
(	NULL
2	NULL
)	NULL
.	NULL

All	NULL
cell	NULL
lines	NULL
were	NULL
grown	NULL
in	NULL
suspension	NULL
cultures	NULL
at	NULL
37°C	NULL
in	NULL
RPMI	NULL
1640	NULL
medium/10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
1	NULL
%	NULL
penicillin-streptomycin/1	NULL
%	NULL
L-glutamine	NULL
in	NULL
a	NULL
humidified	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
atmo-sphere	NULL
.	NULL

Cells	NULL
were	NULL
subcultured	NULL
1:5	NULL
twice	NULL
weekly	NULL
.	NULL

LPS	NULL
(	NULL
Difco	NULL
)	NULL
was	NULL
used	NULL
at	NULL
10	NULL
ug/ml	NULL
.	NULL

HIV	NULL
p24	NULL
antigen	NULL
Elisa	NULL
was	NULL
done	NULL
by	NULL
using	NULL
a	NULL
Retro-Tek	NULL
kit	NULL
(	NULL
Cellular	NULL
Products	NULL
)	NULL
.	NULL

For	NULL
transfections	NULL
,	NULL
cells	NULL
at	NULL
20	NULL
x	NULL
10°	NULL
per	NULL
10	NULL
ug	NULL
of	NULL
plasmid	NULL
were	NULL
subjected	NULL
to	NULL
a	NULL
single	NULL
pulse	NULL
of	NULL
600	NULL
uF	NULL
,	NULL
200	NULL
V	NULL
from	NULL
a	NULL
Biotechnologies	NULL
and	NULL
Experimental	NULL
Research	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
Electro	NULL
cell	NULL
manipulator	NULL
model	NULL
600	NULL
apparatus	NULL
.	NULL

After	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
in	NULL
10	NULL
mi	NULL
of	NULL
growth	NULL
medium	NULL
36-60	NULL
hr	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
for	NULL
nuclear	NULL
extracts	NULL
,	NULL
HIV	NULL
p24	NULL
,	NULL
and	NULL
chloramphenicol	NULL
acetyltransferase	NULL
assay	NULL
(	NULL
12-14	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
p50	NULL
expression	NULL
vectors	NULL
driven	NULL
by	NULL
cytomegalovirus	NULL
promoters	NULL
were	NULL
provided	NULL
by	NULL
A.	NULL
Israel	NULL
(	NULL
Institut	NULL
Pasteur	NULL
,	NULL
Paris	NULL
)	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
Nuclear	NULL
Extracts	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
made	NULL
by	NULL
the	NULL
procedure	NULL
of	NULL
Parker	NULL
and	NULL
Topol	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
cell	NULL
pellet	NULL
was	NULL
washed	NULL
with	NULL
ten	NULL
times	NULL
the	NULL
pellet	NULL
volume	NULL
of	NULL
hypotonic	NULL
buffer	NULL
and	NULL
resuspended	NULL
in	NULL
5	NULL
ml	NULL
of	NULL
hypotonic	NULL
buffer	NULL
Abbreviations	NULL
:	NULL
HIV-1	NULL
,	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
;	NULL
NP-40	NULL
,	NULL
Nonidet	NULL
P-40	NULL
;	NULL
LPS	NULL
,	NULL
lipopolysaccharide	NULL
;	NULL
p50	NULL
,	NULL
a	NULL
protein	NULL
that	NULL
binds	NULL
NF-	NULL
«	NULL
B	NULL
;	NULL
p65	NULL
,	NULL
a	NULL
protein	NULL
that	NULL
complexes	NULL
with	NULL
p50	NULL
;	NULL
LTR	NULL
,	NULL
long	NULL
terminal	NULL
repeat	NULL
;	NULL
IxB	NULL
,	NULL
protein	NULL
that	NULL
can	NULL
inhibit	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
;	NULL
NRE	NULL
,	NULL
negative	NULL
regulatory	NULL
region	NULL
.	NULL

``	NULL
To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Microbiology	NULL
:	NULL
Raziuddin	NULL
et	NULL
al	NULL
.	NULL

with	NULL
1	NULL
mmol	NULL
of	NULL
dithiothreitol	NULL
per	NULL
liter	NULL
of	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
broken	NULL
by	NULL
using	NULL
a	NULL
Dounce	NULL
homogenizer	NULL
.	NULL

After	NULL
restoring	NULL
the	NULL
buffer	NULL
to	NULL
isotonicity	NULL
,	NULL
nuclei	NULL
were	NULL
isolated	NULL
by	NULL
centrifugation	NULL
at	NULL
10,000	NULL
rpm	NULL
for	NULL
10	NULL
min	NULL
with	NULL
a	NULL
JA-21	NULL
rotor	NULL
(	NULL
Beckman	NULL
)	NULL
.	NULL

The	NULL
nuclei	NULL
were	NULL
examined	NULL
under	NULL
light	NULL
microscopy	NULL
,	NULL
and	NULL
~85	NULL
%	NULL
of	NULL
them	NULL
were	NULL
intact	NULL
with	NULL
few	NULL
whole	NULL
cells	NULL
seen	NULL
.	NULL

The	NULL
nuclei	NULL
were	NULL
lysed	NULL
by	NULL
adding	NULL
4	NULL
M	NULL
NH	NULL
,	NULL
SO	NULL
,	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
0.36	NULL
M.	NULL
DNA	NULL
was	NULL
removed	NULL
from	NULL
the	NULL
lysate	NULL
by	NULL
centrifugation	NULL
at	NULL
35,000	NULL
rpm	NULL
for	NULL
1	NULL
hr	NULL
.	NULL

Protein	NULL
was	NULL
precipitated	NULL
from	NULL
the	NULL
clarified	NULL
lysate	NULL
by	NULL
adding	NULL
0.25	NULL
g	NULL
of	NULL
NH	NULL
,	NULL
SO	NULL
,	NULL
per	NULL
ml	NULL
of	NULL
lysate	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
at	NULL
35,000	NULL
rpm	NULL
,	NULL
resuspended	NULL
,	NULL
and	NULL
dialyzed	NULL
against	NULL
a	NULL
buffer	NULL
containing	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
glycerol	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
.	NULL

Some	NULL
nuclear	NULL
extracts	NULL
were	NULL
treated	NULL
with	NULL
sodium	NULL
deoxycholate	NULL
at	NULL
0.8	NULL
%	NULL
and	NULL
then	NULL
with	NULL
Nonidet	NULL
P-40	NULL
(	NULL
NP-40	NULL
)	NULL
at	NULL
1.2	NULL
%	NULL
,	NULL
as	NULL
described	NULL
(	NULL
26	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
was	NULL
purified	NULL
from	NULL
the	NULL
cytosol	NULL
of	NULL
rabbit	NULL
lungs	NULL
with	NULL
a	NULL
final	NULL
step	NULL
of	NULL
affinity	NULL
chromatography	NULL
,	NULL
as	NULL
described	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Antiserum	NULL
.	NULL

Peptides	NULL
derived	NULL
from	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
c-rel	NULL
(	NULL
28	NULL
)	NULL
coupled	NULL
to	NULL
hemocyanin	NULL
as	NULL
well	NULL
as	NULL
a	NULL
peptide	NULL
specific	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
21	NULL
)	NULL
were	NULL
injected	NULL
in	NULL
rabbits	NULL
,	NULL
as	NULL
described	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Polyclonal	NULL
antisera	NULL
specific	NULL
for	NULL
either	NULL
c-re/	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
were	NULL
from	NULL
N.	NULL
Rice	NULL
(	NULL
Advanced	NULL
Biosciences	NULL
Laboratories-Basic	NULL
Science	NULL
Program	NULL
,	NULL
Frederick	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Specific	NULL
peptides	NULL
at	NULL
20	NULL
ng/ml	NULL
were	NULL
used	NULL
for	NULL
unlabeled	NULL
competition	NULL
.	NULL

Gel-Mobility-Shift	NULL
Assay	NULL
.	NULL

For	NULL
DNA-binding	NULL
assays	NULL
,	NULL
the	NULL
pL3CAT	NULL
plasmid	NULL
containing	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
was	NULL
digested	NULL
with	NULL
EcoRII	NULL
,	NULL
dephosphorylated	NULL
with	NULL
calf	NULL
intestinal	NULL
alkaline	NULL
phosphate	NULL
,	NULL
5'-end	NULL
labeled	NULL
with	NULL
[	NULL
y-P	NULL
]	NULL
JATP	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

The	NULL
labeled	NULL
fragment	NULL
was	NULL
digested	NULL
with	NULL
EcoRV	NULL
to	NULL
give	NULL
a	NULL
probe	NULL
containing	NULL
only	NULL
the	NULL
HIV-1	NULL
NF-	NULL
«	NULL
B-binding	NULL
sequences	NULL
from	NULL
-117	NULL
(	NULL
CGAGCTTG	NULL
CTACAAGGGA	NULL
CTTTCCGCTG	NULL
GGGACTTTCC	NULL
AG	NULL
)	NULL
to	NULL
-78	NULL
.	NULL

The	NULL
mutant	NULL
probe	NULL
has	NULL
the	NULL
GGG	NULL
motifs	NULL
replaced	NULL
by	NULL
TCT	NULL
,	NULL
as	NULL
described	NULL
(	NULL
11-14	NULL
)	NULL
,	NULL
which	NULL
was	NULL
purified	NULL
on	NULL
a	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
recovered	NULL
after	NULL
ethanol	NULL
precipitation	NULL
.	NULL

Assays	NULL
slightly	NULL
modified	NULL
from	NULL
Kadonaga	NULL
et	NULL
al	NULL
.	NULL

(	NULL
29	NULL
)	NULL
were	NULL
done	NULL
in	NULL
a	NULL
20-ul	NULL
vol	NULL
containing	NULL
25	NULL
mM	NULL
Hepes	NULL
(	NULL
pH	NULL
7.6	NULL
)	NULL
;	NULL
50	NULL
mM	NULL
KCI	NULL
;	NULL
10	NULL
%	NULL
glycerol	NULL
;	NULL
1.0	NULL
mM	NULL
EDTA	NULL
;	NULL
1.0	NULL
mM	NULL
dithiothreitol	NULL
;	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
;	NULL
0.05	NULL
%	NULL
NP-40	NULL
;	NULL
15,000	NULL
cpm	NULL
of	NULL
the	NULL
probe	NULL
;	NULL
and	NULL
nuclear	NULL
extracts	NULL
at	NULL
10	NULL
ug	NULL
of	NULL
protein	NULL
.	NULL

For	NULL
competition	NULL
studies	NULL
,	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
was	NULL
added	NULL
.	NULL

In	NULL
mixing	NULL
experiments	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
protein	NULL
from	NULL
the	NULL
extract	NULL
to	NULL
inhibit	NULL
was	NULL
mixed	NULL
with	NULL
8	NULL
ug	NULL
of	NULL
protein	NULL
from	NULL
the	NULL
extract	NULL
of	NULL
productively	NULL
infected	NULL
cells	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
incubated	NULL
for	NULL
1	NULL
hr	NULL
at	NULL
30°C	NULL
and	NULL
then	NULL
electrophoresed	NULL
at	NULL
10	NULL
V	NULL
per	NULL
cm	NULL
through	NULL
a	NULL
4	NULL
%	NULL
nonde-naturing	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
Tris/EDTA/borate	NULL
buffer	NULL
.	NULL

DNA-Protein	NULL
(	NULL
'	NULL
``	NULL
Southwestern	NULL
``	NULL
)	NULL
Blot	NULL
Analysis	NULL
.	NULL

Nuclear	NULL
proteins	NULL
(	NULL
100	NULL
mg	NULL
)	NULL
were	NULL
separated	NULL
by	NULL
SDS/PAGE	NULL
(	NULL
10	NULL
%	NULL
separating	NULL
gel	NULL
)	NULL
and	NULL
electrotransferred	NULL
on	NULL
nitrocellulose	NULL
,	NULL
and	NULL
the	NULL
membrane	NULL
was	NULL
washed	NULL
,	NULL
as	NULL
described	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
then	NULL
placed	NULL
in	NULL
a	NULL
heat-sealable	NULL
pouch	NULL
in	NULL
binding	NULL
buffer	NULL
[	NULL
10	NULL
mM	NULL
TrisHCI	NULL
,	NULL
pH	NULL
7.5/40	NULL
mM	NULL
NaCl/1	NULL
mM	NULL
dithiothreitol/1	NULL
mM	NULL
EDTA/8	NULL
%	NULL
(	NULL
vol/	NULL
vol	NULL
)	NULL
glycerol	NULL
nonfat	NULL
dry	NULL
milk	NULL
/60	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
/5	NULL
mM	NULL
MgCl/5	NULL
x	NULL
10°	NULL
cpm	NULL
of	NULL
**P-labeled	NULL
HIV-1	NULL
oligonucleotide	NULL
from	NULL
-216	NULL
to	NULL
-156	NULL
(	NULL
negative	NULL
regulatory	NULL
region	NULL
,	NULL
or	NULL
NRE	NULL
,	NULL
of	NULL
HIV-1	NULL
LTR	NULL
)	NULL
]	NULL
.	NULL

After	NULL
14	NULL
hr	NULL
of	NULL
constant	NULL
agitation	NULL
,	NULL
the	NULL
membrane	NULL
was	NULL
washed	NULL
with	NULL
10	NULL
mM	NULL
TrisHC1/50	NULL
mM	NULL
NaCl	NULL
for	NULL
2	NULL
hr	NULL
at	NULL
25°C	NULL
with	NULL
several	NULL
changes	NULL
and	NULL
exposed	NULL
on	NULL
x-ray	NULL
film	NULL
.	NULL

RESULTS	NULL
Chronically	NULL
infected	NULL
THP-1	NULL
cells	NULL
,	NULL
the	NULL
HIV-1	NULL
expression	NULL
of	NULL
which	NULL
is	NULL
restricted	NULL
,	NULL
initially	NULL
released	NULL
high	NULL
reverse	NULL
transcrip-tase	NULL
and	NULL
p24	NULL
levels	NULL
,	NULL
but	NULL
over	NULL
several	NULL
weeks	NULL
,	NULL
a	NULL
progressive	NULL
decrease	NULL
in	NULL
these	NULL
levels	NULL
was	NULL
seen	NULL
until	NULL
HIV-1	NULL
production	NULL
stabilized	NULL
(	NULL
ref	NULL
.	NULL

2	NULL
,	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
consequences	NULL
of	NULL
this	NULL
restricted	NULL
expression	NULL
in	NULL
THP-1	NULL
cells	NULL
were	NULL
(	NULL
i	NULL
)	NULL
intracellular	NULL
sequestration	NULL
of	NULL
the	NULL
virions	NULL
,	NULL
(	NULL
ii	NULL
)	NULL
markedly	NULL
lower	NULL
accumulation	NULL
of	NULL
viral	NULL
DNA	NULL
,	NULL
and	NULL
(	NULL
ii	NULL
?	NULL
)	NULL

little	NULL
extracellular	NULL
virus	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Terminal	NULL
dilution	NULL
analysis	NULL
of	NULL
viral	NULL
DNA	NULL
by	NULL
PCR	NULL
of	NULL
the	NULL
THP-1	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
9427	NULL
cultures	NULL
with	NULL
restricted	NULL
expression	NULL
used	NULL
in	NULL
these	NULL
studies	NULL
showed	NULL
equivalent	NULL
amounts	NULL
of	NULL
DNA	NULL
compared	NULL
with	NULL
an	NULL
8E5	NULL
cell	NULL
line	NULL
containing	NULL
a	NULL
single	NULL
HIV-1	NULL
copy	NULL
(	NULL
ref	NULL
.	NULL

31	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Nuclear	NULL
run-on	NULL
assays	NULL
indicated	NULL
a	NULL
3-	NULL
to	NULL
4-fold	NULL
decrease	NULL
in	NULL
HIV-1	NULL
transcriptional	NULL
activity	NULL
in	NULL
cells	NULL
with	NULL
restricted	NULL
expression	NULL
compared	NULL
with	NULL
the	NULL
productively	NULL
infected	NULL
cells	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
an	NULL
in	NULL
vivo	NULL
transcription	NULL
assay	NULL
using	NULL
a	NULL
template	NULL
DNA	NULL
derived	NULL
from	NULL
a	NULL
199-bp	NULL
region	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
containing	NULL
the	NULL
enhancer	NULL
and	NULL
RNA	NULL
start	NULL
site	NULL
,	NULL
fewer	NULL
transcripts	NULL
were	NULL
seen	NULL
with	NULL
extracts	NULL
from	NULL
cells	NULL
with	NULL
restricted	NULL
HIV	NULL
expression	NULL
compared	NULL
with	NULL
transcripts	NULL
stimulated	NULL
by	NULL
extracts	NULL
from	NULL
productively	NULL
infected	NULL
cells	NULL
or	NULL
LPS-treated	NULL
cells	NULL
with	NULL
restricted	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Because	NULL
many	NULL
cellular	NULL
transcription	NULL
factors	NULL
play	NULL
a	NULL
role	NULL
in	NULL
regulating	NULL
HIV	NULL
transcription	NULL
by	NULL
binding	NULL
to	NULL
the	NULL
enhancer	NULL
region	NULL
of	NULL
HIV-1	NULL
LTR	NULL
(	NULL
32	NULL
)	NULL
,	NULL
their	NULL
DNA-binding	NULL
capability	NULL
in	NULL
restrictedly	NULL
infected	NULL
cells	NULL
could	NULL
be	NULL
examined	NULL
.	NULL

The	NULL
HIV-1	NULL
enhancer	NULL
contains	NULL
two	NULL
tandem	NULL
repeats	NULL
of	NULL
the	NULL
11-bp	NULL
sequence	NULL
that	NULL
binds	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
and	NULL
gel-mobility-shift	NULL
experiments	NULL
were	NULL
done	NULL
by	NULL
using	NULL
this	NULL
DNA	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Affinity-purified	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
proteins	NULL
show	NULL
three	NULL
DNA-binding	NULL
complex-es-the	NULL
highest	NULL
(	NULL
slowest	NULL
migration	NULL
)	NULL
is	NULL
a	NULL
65-kDa	NULL
plus	NULL
50-kDa	NULL
heterodimer	NULL
followed	NULL
by	NULL
a	NULL
lower	NULL
50-kDa	NULL
homodimer	NULL
and	NULL
a	NULL
proteolytic	NULL
cleavage	NULL
(	NULL
p42	NULL
)	NULL
of	NULL
the	NULL
homodimer	NULL
(	NULL
22-24	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
(	NULL
12	NULL
)	NULL
,	NULL
uninfected	NULL
THP-1	NULL
cells	NULL
,	NULL
as	NULL
well	NULL
as	NULL
freshly	NULL
isolated	NULL
monocytes	NULL
and	NULL
macrophages	NULL
,	NULL
constitutively	NULL
produce	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
leading	NULL
to	NULL
all	NULL
binding	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

These	NULL
complexes	NULL
were	NULL
seen	NULL
in	NULL
the	NULL
nuclear	NULL
extract	NULL
from	NULL
the	NULL
productively	NULL
infected	NULL
cells	NULL
at	NULL
much	NULL
higher	NULL
levels	NULL
,	NULL
but	NULL
the	NULL
uppermost	NULL
band	NULL
(	NULL
the	NULL
heterodimer	NULL
)	NULL
was	NULL
absent	NULL
in	NULL
extracts	NULL
from	NULL
cells	NULL
with	NULL
restricted	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

To	NULL
verify	NULL
that	NULL
specific	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
complexes	NULL
were	NULL
being	NULL
measured	NULL
,	NULL
several	NULL
controls	NULL
were	NULL
done	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
purified	NULL
from	NULL
rabbit	NULL
lung	NULL
,	NULL
as	NULL
de-	NULL
A	NULL
B	NULL
C	NULL
10	NULL
2	NULL
3	NULL
4	NULL
500	NULL
4	NULL
20	NULL
038	NULL
40	NULL
1	NULL
2	NULL
3	NULL
4	NULL
|	NULL
``	NULL
R	NULL
5	NULL
$	NULL
4	NULL
.	NULL

CTC	NULL
M	NULL
.	NULL

u	NULL
FiG	NULL
.	NULL

1	NULL
.	NULL

-	NULL
Gel-mobility-shift	NULL
analysis	NULL
of	NULL
binding	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
sequences	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Binding	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
sequences	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
0.4	NULL
ng	NULL
of	NULL
purified	NULL
NF-KB	NULL
;	NULL
2	NULL
,	NULL
nuclear	NULL
extracts	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
from	NULL
THP-1	NULL
cells	NULL
;	NULL
3	NULL
,	NULL
nuclear	NULL
extracts	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
from	NULL
cells	NULL
with	NULL
restricted	NULL
expression	NULL
.	NULL

4	NULL
,	NULL
P-labeled	NULL
probe	NULL
alone	NULL
;	NULL
5	NULL
,	NULL
nuclear	NULL
extract	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
from	NULL
productively	NULL
infected	NULL
THP-1	NULL
cells	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Effect	NULL
of	NULL
GTP	NULL
on	NULL
DNA	NULL
binding	NULL
.	NULL

Lanes	NULL
:	NULL
2	NULL
and	NULL
4	NULL
,	NULL
3	NULL
mM	NULL
GTP	NULL
in	NULL
20	NULL
mM	NULL
Tris	NULL
HCI	NULL
was	NULL
added	NULL
to	NULL
DNA-binding	NULL
reaction	NULL
mixture	NULL
,	NULL
as	NULL
described	NULL
;	NULL
1	NULL
and	NULL
2	NULL
,	NULL
THP-1	NULL
with	NULL
productive	NULL
expression	NULL
;	NULL
3	NULL
and	NULL
4	NULL
,	NULL
THP-1	NULL
with	NULL
restricted	NULL
expression	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Lack	NULL
of	NULL
binding	NULL
to	NULL
mutated	NULL
NF-	NULL
«	NULL
B	NULL
sequences	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
cells	NULL
with	NULL
productive	NULL
infection	NULL
;	NULL
2	NULL
,	NULL
cells	NULL
with	NULL
restricted	NULL
expression	NULL
;	NULL
3	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
2	NULL
,	NULL
except	NULL
mutant	NULL
probe	NULL
was	NULL
used	NULL
;	NULL
4	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
2	NULL
except	NULL
mutant	NULL
probe	NULL
was	NULL
used	NULL
.	NULL

9428	NULL
Microbiology	NULL
:	NULL
Raziuddin	NULL
et	NULL
al	NULL
.	NULL

scribed	NULL
(	NULL
27	NULL
)	NULL
,	NULL
formed	NULL
the	NULL
same	NULL
complexes	NULL
with	NULL
the	NULL
DNA	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

Because	NULL
millimolar	NULL
amounts	NULL
of	NULL
GTP	NULL
can	NULL
stimulate	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
33	NULL
)	NULL
,	NULL
it	NULL
was	NULL
important	NULL
to	NULL
show	NULL
that	NULL
absence	NULL
of	NULL
binding	NULL
was	NULL
not	NULL
due	NULL
to	NULL
lower	NULL
GTP	NULL
levels	NULL
.	NULL

With	NULL
GTP	NULL
,	NULL
the	NULL
heterodimer	NULL
complexes	NULL
were	NULL
still	NULL
absent	NULL
in	NULL
the	NULL
cells	NULL
with	NULL
restricted	NULL
HIV	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

When	NULL
a	NULL
DNA	NULL
probe	NULL
with	NULL
mutations	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sequences	NULL
was	NULL
used	NULL
(	NULL
11-14	NULL
)	NULL
,	NULL
these	NULL
specific	NULL
binding	NULL
complexes	NULL
were	NULL
no	NULL
longer	NULL
present	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

Because	NULL
previous	NULL
results	NULL
with	NULL
the	NULL
whole	NULL
enhancer	NULL
region	NULL
as	NULL
a	NULL
DNA	NULL
probe	NULL
had	NULL
shown	NULL
that	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
with	NULL
restricted	NULL
infection	NULL
could	NULL
inhibit	NULL
complex	NULL
binding	NULL
by	NULL
using	NULL
extracts	NULL
from	NULL
productively	NULL
infected	NULL
cells	NULL
(	NULL
2	NULL
)	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
the	NULL
same	NULL
was	NULL
true	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
to	NULL
specific	NULL
sequences	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
restricted	NULL
cells	NULL
inhibited	NULL
complex	NULL
formation	NULL
to	NULL
the	NULL
NF-kB	NULL
sequences	NULL
by	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
productively	NULL
infected	NULL
cells	NULL
,	NULL
whereas	NULL
extracts	NULL
from	NULL
uninfected	NULL
cells	NULL
had	NULL
no	NULL
effect	NULL
,	NULL
suggesting	NULL
that	NULL
specific	NULL
inhibitors	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
were	NULL
present	NULL
in	NULL
the	NULL
extract	NULL
from	NULL
cells	NULL
with	NULL
restricted	NULL
expression	NULL
.	NULL

Addition	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
restrictedly	NULL
infected	NULL
cells	NULL
to	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
also	NULL
reduced	NULL
binding	NULL
.	NULL

In	NULL
additional	NULL
specificity	NULL
con-trols	NULL
,	NULL
competitions	NULL
with	NULL
unlabeled	NULL
oligonucleotides	NULL
containing	NULL
normal	NULL
and	NULL
mutated	NULL
NF-	NULL
«	NULL
B	NULL
sequences	NULL
,	NULL
as	NULL
well	NULL
as	NULL
trans-activation	NULL
response	NULL
element	NULL
(	NULL
TAR	NULL
)	NULL
sequences	NULL
,	NULL
were	NULL
done	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

With	NULL
extracts	NULL
from	NULL
productively-infected	NULL
THP-1	NULL
cells	NULL
,	NULL
both	NULL
the	NULL
p50	NULL
homodimer	NULL
and	NULL
pSO-p65	NULL
heterodimer	NULL
bindings	NULL
were	NULL
abolished	NULL
by	NULL
unlabeled	NULL
competition	NULL
with	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
,	NULL
whereas	NULL
no	NULL
effect	NULL
was	NULL
seen	NULL
in	NULL
com	NULL
A	NULL
B	NULL
ro	NULL
to	NULL
p	NULL
on	NULL
o	NULL
~	NULL
co	NULL
No	NULL
to	NULL
+	NULL
5	NULL
co	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Gel-mobility-shift	NULL
analysis	NULL
of	NULL
inhibitory	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
using	NULL
a	NULL
NF-	NULL
«	NULL
B-specific	NULL
probe	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Effect	NULL
of	NULL
mixing	NULL
nuclear	NULL
extracts	NULL
on	NULL
DNA	NULL
binding	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
THP-1	NULL
;	NULL
2	NULL
,	NULL
THP-1	NULL
with	NULL
restricted	NULL
infection	NULL
;	NULL
3	NULL
,	NULL
THP-1	NULL
with	NULL
productive	NULL
infection	NULL
;	NULL
4	NULL
,	NULL
THP-1	NULL
with	NULL
productive	NULL
infection	NULL
plus	NULL
THP-1	NULL
(	NULL
4:1	NULL
ratio	NULL
)	NULL
;	NULL
5	NULL
,	NULL
THP-1	NULL
with	NULL
productive	NULL
infection	NULL
plus	NULL
THP-1	NULL
with	NULL
restricted	NULL
infection	NULL
(	NULL
4:1	NULL
ratio	NULL
)	NULL
;	NULL
6	NULL
,	NULL
probe	NULL
alone	NULL
;	NULL
7	NULL
,	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
0.1	NULL
ng	NULL
)	NULL
plus	NULL
THP-1	NULL
with	NULL
restricted	NULL
expression	NULL
;	NULL
8	NULL
,	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
0.1	NULL
ng	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Oligonucleotide	NULL
competitions	NULL
of	NULL
binding	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
sequences	NULL
with	NULL
and	NULL
without	NULL
50-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
competitor	NULL
oligonucleotides	NULL
.	NULL

Lanes	NULL
1-4	NULL
,	NULL
extracts	NULL
from	NULL
cells	NULL
with	NULL
restricted	NULL
expression	NULL
;	NULL
lanes	NULL
5-8	NULL
,	NULL
extracts	NULL
from	NULL
cells	NULL
with	NULL
productive	NULL
expression	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
5	NULL
contained	NULL
no	NULL
competitor	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
contained	NULL
NF-	NULL
«	NULL
B	NULL
sequences	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
contained	NULL
mutated	NULL
NF-	NULL
«	NULL
B	NULL
sequences	NULL
;	NULL
and	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
contained	NULL
trans-activation	NULL
response	NULL
element	NULL
sequences	NULL
(	NULL
-17	NULL
to	NULL
+82	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
petitions	NULL
with	NULL
a	NULL
mutated	NULL
NF-kB	NULL
or	NULL
a	NULL
trans-activation	NULL
response	NULL
element-region	NULL
oligonucleotide	NULL
.	NULL

As	NULL
previously	NULL
shown	NULL
,	NULL
extracts	NULL
from	NULL
THP-1	NULL
cells	NULL
with	NULL
restricted	NULL
HIV	NULL
expression	NULL
bound	NULL
only	NULL
p50	NULL
;	NULL
this	NULL
binding	NULL
was	NULL
also	NULL
abolished	NULL
only	NULL
by	NULL
an	NULL
unlabeled	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
inhibitory	NULL
activity	NULL
in	NULL
the	NULL
nuclear	NULL
extract	NULL
of	NULL
THP	NULL
cells	NULL
with	NULL
restricted	NULL
expression	NULL
was	NULL
specific	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
and	NULL
not	NULL
a	NULL
general	NULL
proteolytic	NULL
degradation	NULL
of	NULL
the	NULL
extract	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
ability	NULL
of	NULL
this	NULL
extract	NULL
to	NULL
bind	NULL
to	NULL
or	NULL
inhibit	NULL
specific	NULL
binding	NULL
to	NULL
a	NULL
different	NULL
region	NULL
of	NULL
the	NULL
LTR	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Southwestern	NULL
(	NULL
DNA-protein	NULL
)	NULL
analysis	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
NRE	NULL
region	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
shows	NULL
the	NULL
same	NULL
distinct	NULL
bands	NULL
for	NULL
all	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
HeLa	NULL
cells	NULL
can	NULL
bind	NULL
to	NULL
a	NULL
30-mer	NULL
in	NULL
the	NULL
NRE	NULL
region	NULL
of	NULL
HIV-1	NULL
LTR	NULL
.	NULL

Extracts	NULL
from	NULL
THP-1	NULL
cells	NULL
with	NULL
restricted	NULL
expression	NULL
could	NULL
not	NULL
inhibit	NULL
this	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
or	NULL
binding	NULL
of	NULL
the	NULL
Oct-1	NULL
factor	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
protein	NULL
degradation	NULL
did	NULL
not	NULL
contribute	NULL
to	NULL
the	NULL
inhibitory	NULL
activity	NULL
of	NULL
the	NULL
extracts	NULL
.	NULL

Furthermore	NULL
,	NULL
addition	NULL
of	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
to	NULL
the	NULL
extracts	NULL
from	NULL
cells	NULL
with	NULL
restricted	NULL
infection	NULL
resulted	NULL
in	NULL
a	NULL
recovery	NULL
of	NULL
the	NULL
higher	NULL
DNA-binding	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

Because	NULL
exogenous	NULL
addition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
overcame	NULL
the	NULL
inhibitory	NULL
activity	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
an	NULL
endogenous	NULL
treatment	NULL
could	NULL
overcome	NULL
this	NULL
inhibition	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
had	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
present	NULL
in	NULL
the	NULL
cytosol	NULL
of	NULL
cells	NULL
bound	NULL
to	NULL
an	NULL
inhibitory	NULL
protein	NULL
,	NULL
IxB	NULL
,	NULL
which	NULL
can	NULL
inhibit	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
a	NULL
reversible	NULL
and	NULL
specific	NULL
manner	NULL
(	NULL
26	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Sodium	NULL
MW	NULL
110	NULL
84	NULL
w*	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Southwestern	NULL
(	NULL
DNA-protein	NULL
)	NULL
analysis	NULL
of	NULL
binding	NULL
to	NULL
NRE	NULL
region	NULL
of	NULL
HIV-1	NULL
LTR	NULL
.	NULL

A	NULL
*P-labeled	NULL
probe	NULL
containing	NULL
the	NULL
HIV-1	NULL
NRE	NULL
binding	NULL
sequences	NULL
from	NULL
-340	NULL
to	NULL
-216	NULL
was	NULL
used	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
restricted	NULL
THP-1	NULL
;	NULL
2	NULL
,	NULL
productive	NULL
THP-1	NULL
;	NULL
3	NULL
,	NULL
THP-1	NULL
;	NULL
4	NULL
,	NULL
HeLa	NULL
cells	NULL
;	NULL
5	NULL
,	NULL
Control	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Effect	NULL
of	NULL
extracts	NULL
from	NULL
restricted	NULL
cells	NULL
on	NULL
binding	NULL
to	NULL
HIV-LTR	NULL
NRE	NULL
region	NULL
.	NULL

A	NULL
*P-labeled	NULL
probe	NULL
containing	NULL
the	NULL
HIV-1	NULL
NRE	NULL
binding	NULL
sequences	NULL
from	NULL
-156	NULL
to	NULL
-126	NULL
was	NULL
used	NULL
.	NULL

Lanes	NULL
1-4	NULL
contained	NULL
extract	NULL
from	NULL
HeLa	NULL
cells	NULL
(	NULL
2.5	NULL
ug	NULL
)	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
no	NULL
competitor	NULL
extract	NULL
;	NULL
2	NULL
,	NULL
extract	NULL
from	NULL
THP-1	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
;	NULL
3	NULL
,	NULL
extract	NULL
from	NULL
THP-1	NULL
with	NULL
restricted	NULL
expression	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
;	NULL
4	NULL
,	NULL
extract	NULL
from	NULL
THP-1	NULL
cells	NULL
with	NULL
productive	NULL
expression	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Effects	NULL
of	NULL
mutant	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
on	NULL
DNA	NULL
binding	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
THP-1	NULL
with	NULL
productive	NULL
infection	NULL
plus	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
0.2	NULL
ng	NULL
)	NULL
;	NULL
2	NULL
,	NULL
THP-1	NULL
with	NULL
restricted	NULL
infection	NULL
plus	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
0.2	NULL
ng	NULL
)	NULL
;	NULL
3	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
1	NULL
,	NULL
except	NULL
mutant	NULL
probe	NULL
was	NULL
used	NULL
;	NULL
4	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
2	NULL
,	NULL
except	NULL
mutant	NULL
probe	NULL
was	NULL
used	NULL
.	NULL

At	NULL
left	NULL
are	NULL
M	NULL
,	NULL
(	NULL
x	NULL
10~	NULL
>	NULL
)	NULL
markers	NULL
.	NULL

Microbiology	NULL
:	NULL
Raziuddin	NULL
et	NULL
al	NULL
.	NULL

deoxycholate	NULL
can	NULL
release	NULL
IxB	NULL
and	NULL
thus	NULL
activate	NULL
NF-KB	NULL
(	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
uninfected	NULL
and	NULL
infected	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
sodium	NULL
deoxycholate	NULL
,	NULL
incubated	NULL
with	NULL
NP-40	NULL
,	NULL
and	NULL
then	NULL
used	NULL
in	NULL
gel-mobility	NULL
assays	NULL
,	NULL
as	NULL
described	NULL
(	NULL
34	NULL
)	NULL
.	NULL

As	NULL
has	NULL
been	NULL
shown	NULL
,	NULL
sodium	NULL
deoxycholate	NULL
at	NULL
0.8	NULL
%	NULL
inhibited	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
incubation	NULL
with	NULL
NP-40	NULL
,	NULL
a	NULL
nonionic	NULL
detergent	NULL
,	NULL
can	NULL
sequester	NULL
sodium	NULL
deoxycholate	NULL
out	NULL
of	NULL
solution	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
with	NULL
restricted	NULL
infection	NULL
could	NULL
now	NULL
form	NULL
the	NULL
heterodimer	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Extracts	NULL
from	NULL
productively	NULL
infected	NULL
cells	NULL
also	NULL
modestly	NULL
increased	NULL
heterodimer-binding	NULL
activity	NULL
after	NULL
treatment	NULL
with	NULL
sodium	NULL
deoxycholate	NULL
and	NULL
NP-40	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
;	NULL
thus	NULL
,	NULL
this	NULL
increase	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
was	NULL
not	NULL
limited	NULL
to	NULL
cells	NULL
with	NULL
restricted	NULL
expression	NULL
.	NULL

This	NULL
DNA-binding	NULL
seen	NULL
after	NULL
sodium	NULL
deoxycholate	NULL
and	NULL
NP-40	NULL
treatment	NULL
was	NULL
also	NULL
specific	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
lack	NULL
of	NULL
binding	NULL
to	NULL
a	NULL
probe	NULL
containing	NULL
a	NULL
mutant	NULL
NF-	NULL
«	NULL
B-binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Several	NULL
groups	NULL
have	NULL
shown	NULL
that	NULL
many	NULL
stimuli	NULL
can	NULL
enhance	NULL
viral	NULL
expression	NULL
in	NULL
chronically	NULL
infected	NULL
cells	NULL
with	NULL
restricted	NULL
expression	NULL
(	NULL
8-12	NULL
)	NULL
.	NULL

In	NULL
THP-1	NULL
cells	NULL
,	NULL
LPS	NULL
at	NULL
10	NULL
ug/ml	NULL
for	NULL
48	NULL
hr	NULL
stimulates	NULL
a	NULL
10-fold	NULL
increase	NULL
in	NULL
viral	NULL
production	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
LPS	NULL
treatment	NULL
of	NULL
THP-1	NULL
cells	NULL
with	NULL
restricted	NULL
HIV-1	NULL
expression	NULL
increases	NULL
binding	NULL
activity	NULL
of	NULL
65-kDa	NULL
plus	NULL
50-kDa	NULL
heterodimer	NULL
,	NULL
which	NULL
approaches	NULL
that	NULL
of	NULL
productively	NULL
infected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
10	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
vector	NULL
in	NULL
these	NULL
cells	NULL
increased	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
and	NULL
viral	NULL
production	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

All	NULL
data	NULL
suggest	NULL
that	NULL
lack	NULL
of	NULL
optimal	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
provides	NULL
at	NULL
least	NULL
one	NULL
mechanism	NULL
for	NULL
restricted	NULL
HIV-1	NULL
expression	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

7	NULL
8	NULL
9	NULL
10	NULL
1112	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Effect	NULL
of	NULL
dissociating	NULL
agents	NULL
on	NULL
NF-KB	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
THP-1	NULL
with	NULL
restricted	NULL
HIV-1	NULL
expression	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
treated	NULL
with	NULL
0.8	NULL
%	NULL
sodium	NULL
deoxycholate	NULL
followed	NULL
by	NULL
incubation	NULL
with	NULL
and	NULL
without	NULL
Nonidet	NULL
P-40	NULL
at	NULL
1.2	NULL
%	NULL
final	NULL
concentra-tion	NULL
,	NULL
as	NULL
described	NULL
(	NULL
24	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
THP-1	NULL
with	NULL
restricted	NULL
expression	NULL
;	NULL
2	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
1	NULL
treated	NULL
with	NULL
0.8	NULL
%	NULL
sodium	NULL
deoxycholate	NULL
;	NULL
3	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
2	NULL
followed	NULL
by	NULL
NP-40	NULL
incubation	NULL
;	NULL
4	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
3	NULL
,	NULL
except	NULL
mutant	NULL
probe	NULL
was	NULL
used	NULL
;	NULL
5	NULL
,	NULL
THP-1	NULL
with	NULL
productive	NULL
HIV-1	NULL
expression	NULL
;	NULL
6	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
5	NULL
treated	NULL
with	NULL
0.8	NULL
%	NULL
sodium	NULL
deoxycholate	NULL
;	NULL
7	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
6	NULL
treated	NULL
with	NULL
NP-40	NULL
;	NULL
8	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
7	NULL
with	NULL
mutant	NULL
probe	NULL
;	NULL
9	NULL
,	NULL
extract	NULL
from	NULL
THP-1	NULL
cells	NULL
with	NULL
restricted	NULL
expression	NULL
with	NULL
a	NULL
second	NULL
HIV-1	NULL
isolate	NULL
,	NULL
RF	NULL
;	NULL
10	NULL
,	NULL
extract	NULL
from	NULL
same	NULL
cells	NULL
as	NULL
lane	NULL
9	NULL
treated	NULL
with	NULL
LPS	NULL
for	NULL
48	NULL
hr	NULL
;	NULL
11	NULL
,	NULL
extract	NULL
from	NULL
cells	NULL
productively	NULL
infected	NULL
with	NULL
isolate	NULL
RF	NULL
;	NULL
12	NULL
,	NULL
extract	NULL
from	NULL
THP-1	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
9429	NULL
Table	NULL
1	NULL
.	NULL

-	NULL
Analysis	NULL
of	NULL
virally	NULL
infected	NULL
THP-1	NULL
cells	NULL
Viral	NULL
P24	NULL
antigen	NULL
,	NULL
CAT	NULL
activity	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
expression	NULL
ng/ml	NULL
%	NULL
conversion	NULL
(	NULL
heterodimer	NULL
)	NULL
None	NULL
0	NULL
12	NULL
++	NULL
Producer	NULL
200-500	NULL
78	NULL
+++	NULL
Restricted	NULL
0.05-20	NULL
25	NULL
+/-Restricted	NULL
+	NULL
LPS*	NULL
100-200	NULL
75	NULL
++	NULL
THP-1	NULL
cells	NULL
were	NULL
grown	NULL
and	NULL
infected	NULL
with	NULL
the	NULL
RF	NULL
strain	NULL
of	NULL
HIV-1	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Values	NULL
are	NULL
for	NULL
at	NULL
least	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

*Cells	NULL
were	NULL
treated	NULL
with	NULL
LPS	NULL
at	NULL
10	NULL
ug/ml	NULL
for	NULL
48	NULL
hr	NULL
,	NULL
and	NULL
the	NULL
viral	NULL
assays	NULL
were	NULL
then	NULL
done	NULL
.	NULL

CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
.	NULL

Because	NULL
molecular	NULL
cloning	NULL
of	NULL
c-re/	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
proteins	NULL
have	NULL
shown	NULL
that	NULL
they	NULL
represent	NULL
a	NULL
family	NULL
of	NULL
cellular	NULL
transcription	NULL
factors	NULL
that	NULL
can	NULL
bind	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
sequences	NULL
(	NULL
36	NULL
,	NULL
37	NULL
)	NULL
,	NULL
it	NULL
became	NULL
important	NULL
to	NULL
determine	NULL
which	NULL
proteins	NULL
were	NULL
being	NULL
prevented	NULL
from	NULL
forming	NULL
the	NULL
heterodimer	NULL
.	NULL

Addition	NULL
of	NULL
an	NULL
antibody	NULL
specific	NULL
to	NULL
NF-kB	NULL
profoundly	NULL
decreased	NULL
both	NULL
heterodimer	NULL
and	NULL
homodimer	NULL
binding	NULL
by	NULL
extracts	NULL
from	NULL
productively	NULL
infected	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
sodium	NULL
deoxycholate-treated	NULL
extracts	NULL
from	NULL
restrictedly	NULL
infected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
two	NULL
antisera	NULL
specific	NULL
for	NULL
c-rel	NULL
have	NULL
no	NULL
effect	NULL
on	NULL
complex	NULL
formation	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
inhibitory	NULL
activity	NULL
was	NULL
predominantly	NULL
directed	NULL
against	NULL
NF-KB	NULL
.	NULL

DISCUSSION	NULL
Many	NULL
cellular	NULL
proteins	NULL
contribute	NULL
to	NULL
HIV	NULL
-1	NULL
production	NULL
,	NULL
including	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
which	NULL
bind	NULL
to	NULL
sequences	NULL
in	NULL
the	NULL
LTR	NULL
and	NULL
increase	NULL
viral	NULL
transcription	NULL
.	NULL

During	NULL
productive	NULL
1	NULL
20	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
Antisera	NULL
-	NULL
-	NULL
N	NULL
N	NULL
R1	NULL
R1	NULL
R2	NULL
R2	NULL
-	NULL
N	NULL
Ri	NULL
N2	NULL
Competitor	NULL
-	NULL
ks	NULL
ook	NULL
oom	NULL
eo	NULL
p	NULL
>	NULL
ome	NULL
oms	NULL
om	NULL
Extract	NULL
to	NULL
$	NULL
0	NULL
40	NULL
#	NULL
0	NULL
#	NULL
0	NULL
#	NULL
0	NULL
$	NULL
0	NULL
#	NULL
0	NULL
$	NULL
00	NULL
-	NULL
#	NULL
``	NULL
Mm	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Reactivity	NULL
of	NULL
nuclear	NULL
extracts	NULL
with	NULL
antiserum	NULL
.	NULL

Sodium	NULL
deoxycholate-	NULL
and	NULL
NP-40-treated	NULL
extracts	NULL
were	NULL
from	NULL
restrictedly	NULL
infected	NULL
cells	NULL
.	NULL

Lane	NULL
1	NULL
was	NULL
treated	NULL
with	NULL
0.6	NULL
%	NULL
sodium	NULL
deoxycholate	NULL
,	NULL
and	NULL
all	NULL
others	NULL
were	NULL
at	NULL
1.2	NULL
%	NULL
.	NULL

N	NULL
,	NULL
NF-	NULL
«	NULL
B-specific	NULL
antiserum	NULL
;	NULL
R1	NULL
and	NULL
R2	NULL
,	NULL
specific	NULL
c-rel	NULL
antisera	NULL
;	NULL
competitor	NULL
is	NULL
peptide	NULL
used	NULL
to	NULL
derive	NULL
antisera	NULL
.	NULL

Lane	NULL
8	NULL
,	NULL
no	NULL
probe	NULL
;	NULL
lanes	NULL
9-12	NULL
,	NULL
no	NULL
extracts	NULL
added	NULL
.	NULL

9430	NULL
Microbiology	NULL
:	NULL
Raziuddin	NULL
et	NULL
al	NULL
.	NULL

infection	NULL
of	NULL
U937	NULL
cells	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
specifically	NULL
induced	NULL
(	NULL
38	NULL
)	NULL
,	NULL
and	NULL
it	NULL
can	NULL
be	NULL
regulated	NULL
by	NULL
the	NULL
HIV-1	NULL
protease	NULL
(	NULL
39	NULL
)	NULL
.	NULL

At	NULL
least	NULL
in	NULL
monocytic	NULL
cells	NULL
,	NULL
the	NULL
formation	NULL
of	NULL
both	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
50-kDa	NULL
homodimer	NULL
and	NULL
the	NULL
65-kDa	NULL
plus	NULL
50-kDa	NULL
heterodimer	NULL
is	NULL
required	NULL
for	NULL
optimal	NULL
HIV-1	NULL
transcription	NULL
,	NULL
producing	NULL
higher	NULL
virus	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
these	NULL
chronically	NULL
infected	NULL
cells	NULL
,	NULL
viral	NULL
transcription	NULL
can	NULL
be	NULL
negatively	NULL
regulated	NULL
by	NULL
preferentially	NULL
blocking	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
65-kDa	NULL
plus	NULL
50-kDa	NULL
heterodimer	NULL
DNA-binding	NULL
complex	NULL
(	NULL
Figs	NULL
.	NULL

1-3	NULL
)	NULL
.	NULL

Many	NULL
inducible	NULL
signals	NULL
such	NULL
as	NULL
LPS	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
,	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
,	NULL
which	NULL
increase	NULL
viral	NULL
production	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
8-12	NULL
)	NULL
,	NULL
accomplish	NULL
this	NULL
on	NULL
at	NULL
least	NULL
one	NULL
level	NULL
by	NULL
increasing	NULL
NF-	NULL
«	NULL
B-binding	NULL
activity	NULL
(	NULL
11-14	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
production	NULL
of	NULL
many	NULL
cytokines	NULL
,	NULL
including	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
,	NULL
interleukin	NULL
6	NULL
,	NULL
and	NULL
granulocyte/macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
which	NULL
augment	NULL
HIV-1	NULL
production	NULL
,	NULL
is	NULL
stimulated	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
(	NULL
13-19	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
positive	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
regulates	NULL
the	NULL
level	NULL
of	NULL
HIV-1	NULL
production	NULL
.	NULL

However	NULL
,	NULL
other	NULL
transcription	NULL
factors	NULL
like	NULL
Spl	NULL
may	NULL
also	NULL
contribute	NULL
to	NULL
this	NULL
process	NULL
similarly	NULL
.	NULL

In	NULL
studying	NULL
the	NULL
mechanism	NULL
leading	NULL
to	NULL
a	NULL
preferential	NULL
block	NULL
in	NULL
formation	NULL
of	NULL
the	NULL
65-kDa	NULL
plus	NULL
50-kDa	NULL
heterodimer	NULL
DNA-binding	NULL
complex	NULL
,	NULL
several	NULL
results	NULL
suggest	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Mixing	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
cells	NULL
with	NULL
restricted	NULL
expression	NULL
can	NULL
block	NULL
complex	NULL
formation	NULL
by	NULL
nuclear	NULL
extracts	NULL
from	NULL
productively	NULL
infected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
the	NULL
extracts	NULL
from	NULL
restrictedly	NULL
infected	NULL
cells	NULL
do	NULL
not	NULL
inhibit	NULL
binding	NULL
to	NULL
other	NULL
regions	NULL
of	NULL
the	NULL
LTR	NULL
and	NULL
bind	NULL
normally	NULL
to	NULL
other	NULL
regions	NULL
indicates	NULL
that	NULL
nonspecific	NULL
degradation	NULL
is	NULL
unlikely	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Purified	NULL
NF-	NULL
«	NULL
B	NULL
can	NULL
restore	NULL
complex	NULL
formation	NULL
when	NULL
added	NULL
to	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
cells	NULL
with	NULL
restricted	NULL
expression	NULL
.	NULL

Treatment	NULL
of	NULL
these	NULL
nuclear	NULL
extracts	NULL
with	NULL
sodium	NULL
deoxycholate	NULL
restores	NULL
specific	NULL
heterodimer	NULL
complex	NULL
formation	NULL
.	NULL

Antisera	NULL
specific	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
markedly	NULL
block	NULL
heterodimer	NULL
,	NULL
whereas	NULL
c-re/-specific	NULL
antisera	NULL
do	NULL
not	NULL
,	NULL
suggesting	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
is	NULL
specifically	NULL
inhib-ited	NULL
.	NULL

Finally	NULL
,	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
vector	NULL
increases	NULL
LTR	NULL
activity	NULL
and	NULL
viral	NULL
production	NULL
in	NULL
restrictedly	NULL
infected	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
protein	NULL
IxB	NULL
has	NULL
been	NULL
found	NULL
to	NULL
be	NULL
a	NULL
cytosolic	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B-binding	NULL
activity	NULL
(	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

The	NULL
facts	NULL
that	NULL
the	NULL
interaction	NULL
between	NULL
IxB	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
reversible	NULL
by	NULL
sodium	NULL
deoxycholate	NULL
treatment	NULL
(	NULL
34	NULL
)	NULL
,	NULL
that	NULL
IxB	NULL
binds	NULL
specifically	NULL
to	NULL
the	NULL
65-kDa	NULL
subunit	NULL
and	NULL
blocks	NULL
only	NULL
heterodimer	NULL
formation	NULL
(	NULL
22-24	NULL
)	NULL
,	NULL
and	NULL
that	NULL
it	NULL
rapidly	NULL
dissociates	NULL
the	NULL
complex	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
with	NULL
its	NULL
cognate	NULL
DNA	NULL
(	NULL
35	NULL
)	NULL
suggest	NULL
that	NULL
the	NULL
IxB-like	NULL
molecule	NULL
could	NULL
be	NULL
involved	NULL
in	NULL
this	NULL
negative	NULL
regulation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
and	NULL
that	NULL
IxB-like	NULL
molecules	NULL
can	NULL
be	NULL
present	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
an	NULL
IxB-like	NULL
molecule	NULL
cloned	NULL
from	NULL
monocytes	NULL
was	NULL
found	NULL
in	NULL
the	NULL
nucleus	NULL
and	NULL
specifically	NULL
inhibited	NULL
the	NULL
heterodimer	NULL
complex	NULL
formation	NULL
(	NULL
40	NULL
)	NULL
.	NULL

These	NULL
results	NULL
,	NULL
along	NULL
with	NULL
the	NULL
inability	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
uninfected	NULL
and	NULL
productively	NULL
infected	NULL
cells	NULL
to	NULL
be	NULL
inhibitory	NULL
,	NULL
make	NULL
it	NULL
unlikely	NULL
that	NULL
cytoplasmic	NULL
material	NULL
is	NULL
involved	NULL
.	NULL

Because	NULL
in	NULL
some	NULL
experiments	NULL
the	NULL
p50	NULL
homodimer	NULL
was	NULL
also	NULL
suppressed	NULL
,	NULL
there	NULL
could	NULL
be	NULL
other	NULL
alternative	NULL
inhibitory	NULL
pathways	NULL
,	NULL
but	NULL
the	NULL
interaction	NULL
between	NULL
65-kDa	NULL
and	NULL
50-kDa	NULL
subunits	NULL
is	NULL
a	NULL
preferential	NULL
target	NULL
.	NULL

Regardless	NULL
of	NULL
the	NULL
mechanism	NULL
,	NULL
these	NULL
results	NULL
demonstrate	NULL
that	NULL
HIV-1	NULL
gene	NULL
expression	NULL
can	NULL
be	NULL
negatively	NULL
regulated	NULL
through	NULL
the	NULL
interactions	NULL
of	NULL
cellular	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

We	NULL
thank	NULL
Dr.	NULL
Dan	NULL
L.	NULL
Longo	NULL
for	NULL
many	NULL
helpful	NULL
discussions	NULL
and	NULL
for	NULL
reviewing	NULL
this	NULL
manuscript	NULL
and	NULL
Carla	NULL
Hemp	NULL
for	NULL
excellent	NULL
editorial	NULL
assistance	NULL
.	NULL

This	NULL
project	NULL
has	NULL
been	NULL
funded	NULL
,	NULL
in	NULL
part	NULL
,	NULL
by	NULL
the	NULL
Department	NULL
of	NULL
Health	NULL
and	NULL
Human	NULL
Services	NULL
under	NULL
Contract	NULL
NO1-CO-74102	NULL
with	NULL
Program	NULL
Resources	NULL
,	NULL
Inc./DynCorp	NULL
.	NULL

1	NULL
.	NULL

Ranki	NULL
,	NULL
A.	NULL
,	NULL
Valle	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Krohn	NULL
,	NULL
M.	NULL
,	NULL
Antonen	NULL
,	NULL
J.	NULL
,	NULL
Allain	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Leuther	NULL
,	NULL
M.	NULL
,	NULL
Franchini	NULL
,	NULL
G.	NULL
&	NULL
Krohn	NULL
,	NULL
K.	NULL
(	NULL
1987	NULL
)	NULL
Lancet	NULL
ii	NULL
,	NULL
589-593	NULL
.	NULL

2	NULL
.	NULL

Mikovits	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Raziuddin	NULL
,	NULL
Gonda	NULL
,	NULL
M.	NULL
,	NULL
Ruta	NULL
,	NULL
M.	NULL
,	NULL
Lohrey	NULL
,	NULL
N.	NULL
,	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
Kung	NULL
,	NULL
H.	NULL
F.	NULL
&	NULL
Ruscetti	NULL
,	NULL
F.	NULL
W.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171	NULL
,	NULL
1705-1720	NULL
.	NULL

Folks	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Justement	NULL
,	NULL
J.	NULL
,	NULL
Kinter	NULL
,	NULL
A.	NULL
,	NULL
Schnittman	NULL
,	NULL
S.	NULL
,	NULL
Orsen-stein	NULL
,	NULL
J.	NULL
,	NULL
Poli	NULL
,	NULL
G.	NULL
&	NULL
Fauci	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

140	NULL
,	NULL
1117-1122	NULL
.	NULL

Pauza	NULL
,	NULL
C.	NULL
,	NULL
Galindo	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Richman	NULL
,	NULL
D.	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

62	NULL
,	NULL
3558-3564	NULL
.	NULL

Gendelman	NULL
,	NULL
H.	NULL
,	NULL
Narayan	NULL
,	NULL
O.	NULL
,	NULL
Kennedy-Stoskopf	NULL
,	NULL
S.	NULL
,	NULL
Ken-nedy	NULL
,	NULL
P.	NULL
,	NULL
Ghotbi	NULL
,	NULL
Z.	NULL
,	NULL
Clements	NULL
,	NULL
J.	NULL
,	NULL
Stanley	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Pezeshkpour	NULL
,	NULL
G.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

58	NULL
,	NULL
67-75	NULL
.	NULL

Ho	NULL
,	NULL
D.	NULL
,	NULL
Trota	NULL
,	NULL
T.	NULL
&	NULL
Hirsch	NULL
,	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

77	NULL
,	NULL
1712-1715	NULL
.	NULL

Nicolson	NULL
,	NULL
J.	NULL
,	NULL
Cross	NULL
,	NULL
G.	NULL
,	NULL
Callaway	NULL
,	NULL
C.	NULL
&	NULL
McCongal	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

137	NULL
,	NULL
323-329	NULL
.	NULL

Tong-Starksen	NULL
,	NULL
S.	NULL
,	NULL
Luciw	NULL
,	NULL
P.	NULL
&	NULL
Peterlin	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84	NULL
,	NULL
6845-6849	NULL
.	NULL

Folks	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Justement	NULL
,	NULL
J.	NULL
,	NULL
Kinter	NULL
,	NULL
A.	NULL
,	NULL
Dinarello	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

&	NULL
Fauci	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
238	NULL
,	NULL
800-802	NULL
.	NULL

Hammer	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Gillia	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Groopman	NULL
,	NULL
J.	NULL
E.	NULL
&	NULL
Rose	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83	NULL
,	NULL
8734-8738	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
326	NULL
,	NULL
711-713	NULL
.	NULL

Griffin	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
Leung	NULL
,	NULL
K.	NULL
,	NULL
Folks	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Kunkel	NULL
,	NULL
S.	NULL
&	NULL
Nabel	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
339	NULL
,	NULL
70-73	NULL
.	NULL

Osborn	NULL
,	NULL
L.	NULL
,	NULL
Kunkel	NULL
,	NULL
S.	NULL
&	NULL
Nabel	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
2336-2340	NULL
.	NULL

Duh	NULL
,	NULL
E.	NULL
,	NULL
Maury	NULL
,	NULL
W.	NULL
,	NULL
Folks	NULL
,	NULL
T.	NULL
,	NULL
Fauci	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Rabson	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
5974-5978	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
46	NULL
,	NULL
705-716	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
&	NULL
Sharp	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
305-313	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
,	NULL
Halden	NULL
,	NULL
N.	NULL
,	NULL
Lenardo	NULL
,	NULL
M.	NULL
&	NULL
Leonard	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
244	NULL
,	NULL
466-469	NULL
.	NULL

Collart	NULL
,	NULL
M.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Vassalli	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
1498-1504	NULL
.	NULL

Libermann	NULL
,	NULL
T.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
2327-2335	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Gifford	NULL
,	NULL
A.	NULL
,	NULL
Riviere	NULL
,	NULL
L.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1019-1029	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Logeat	NULL
,	NULL
F.	NULL
,	NULL
Vandekerckhove	NULL
,	NULL
J.	NULL
,	NULL
Lottspeich	NULL
,	NULL
F.	NULL
,	NULL
LeBail	NULL
,	NULL
O.	NULL
,	NULL
Urban	NULL
,	NULL
M.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1007-1018	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
961-969	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

3	NULL
,	NULL
1689-1698	NULL
.	NULL

Urban	NULL
,	NULL
M.	NULL
&	NULL
Bacuerle	NULL
,	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
New	NULL
Biol	NULL
.	NULL

3	NULL
,	NULL
279-288	NULL
.	NULL

Parker	NULL
,	NULL
C.	NULL
S.	NULL
&	NULL
Topol	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Cell	NULL
36	NULL
,	NULL
357-366	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
53	NULL
,	NULL
211-217	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
344	NULL
,	NULL
678-682	NULL
.	NULL

Brownell	NULL
,	NULL
E.	NULL
,	NULL
Mittereder	NULL
,	NULL
N.	NULL
&	NULL
Rice	NULL
,	NULL
N.	NULL
(	NULL
1989	NULL
)	NULL
Oncogene	NULL
4	NULL
,	NULL
935-942	NULL
.	NULL

Kadonaga	NULL
,	NULL
J.	NULL
,	NULL
Carner	NULL
,	NULL
K.	NULL
,	NULL
Masiarz	NULL
,	NULL
F.	NULL
&	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
51	NULL
,	NULL
1079-1090	NULL
.	NULL

Marriott	NULL
,	NULL
S.	NULL
,	NULL
Lindholm	NULL
,	NULL
P.	NULL
,	NULL
Brown	NULL
,	NULL
K.	NULL
,	NULL
Gitlin	NULL
,	NULL
S.	NULL
,	NULL
Duvall	NULL
,	NULL
J.	NULL
,	NULL
Radonovich	NULL
,	NULL
M.	NULL
&	NULL
Brady	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
4192-4201	NULL
.	NULL

Folks	NULL
,	NULL
T.	NULL
,	NULL
Powell	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Lightfoote	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Benn	NULL
,	NULL
S.	NULL
,	NULL
Martin	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

&	NULL
Fauci	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1986	NULL
)	NULL
Science	NULL
231	NULL
,	NULL
600-604	NULL
.	NULL

Jones	NULL
,	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
New	NULL
Biol	NULL
.	NULL

1	NULL
,	NULL
127-135	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
,	NULL
Kuang	NULL
,	NULL
A.	NULL
,	NULL
Glifford	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85	NULL
,	NULL
8825-8829	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
242	NULL
,	NULL
540-546	NULL
.	NULL

Zabel	NULL
,	NULL
U	NULL
.	NULL

&	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
61	NULL
,	NULL
255-265	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
,	NULL
Walker	NULL
,	NULL
W.	NULL
,	NULL
Doerra	NULL
,	NULL
S.	NULL
,	NULL
Sista	NULL
,	NULL
P.	NULL
,	NULL
Molitor	NULL
,	NULL
J.	NULL
,	NULL
Dixon	NULL
,	NULL
E.	NULL
,	NULL
Peffer	NULL
,	NULL
N.	NULL
,	NULL
Hannink	NULL
,	NULL
M.	NULL
&	NULL
Greene	NULL
,	NULL
W.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
63	NULL
,	NULL
803-814	NULL
.	NULL

Kabrun	NULL
,	NULL
N.	NULL
,	NULL
Hodgson	NULL
,	NULL
J.	NULL
,	NULL
Doemer	NULL
,	NULL
M.	NULL
,	NULL
Mak	NULL
,	NULL
G.	NULL
,	NULL
Franza	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Enrietto	NULL
,	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
1783-1787	NULL
.	NULL

Bachelerie	NULL
,	NULL
F.	NULL
,	NULL
Alcami	NULL
,	NULL
J.	NULL
,	NULL
Arenzana-Seisdedos	NULL
,	NULL
F.	NULL
&	NULL
Vire-lizer	NULL
,	NULL
J.-L.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
350	NULL
,	NULL
709-712	NULL
.	NULL

Riviere	NULL
,	NULL
Y.	NULL
,	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
&	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
350	NULL
,	NULL
625-626	NULL
.	NULL

Haskill	NULL
,	NULL
S.	NULL
,	NULL
Beg	NULL
,	NULL
A.	NULL
,	NULL
Tompkins	NULL
,	NULL
S.	NULL
,	NULL
Morris	NULL
,	NULL
J.	NULL
,	NULL
Yurochko	NULL
,	NULL
A.	NULL
,	NULL
Sampson	NULL
,	NULL
A.	NULL
,	NULL
Mondal	NULL
,	NULL
K.	NULL
,	NULL
Ralph	NULL
,	NULL
P.	NULL
&	NULL
Baldwin	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cell	NULL
65	NULL
,	NULL
1281-1289	NULL
.	NULL

